FDA Approves Key Sanofi Diabetes Drug

The U.S. FDA has approved Sanofi's diabetes drug Toujeo, a more potent follow-up to the drugmaker's top-selling insulin product Lantus.

Source: PharmaManufacturing.com - February 26, 2015 Category: Pharmaceuticals Source Type: news